| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |